MedTrace Logo

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery

NCT00517452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2011-01-05

No results posted yet for this study

Summary

The use of platelet rich plasma will decrease wound infection postop.

Conditions

Sponsors & Collaborators

  • Zimmer Biomet

    collaborator INDUSTRY

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Kirk D Lawlor · London Health Sciences Centre, University of Western Ontario

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Completion
2007-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00517452 on ClinicalTrials.gov